Comparison of ischemic and bleeding events between short versus long duration tirofiban regimens in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention

• Published in: Journal of cardiovascular pharmacology
• Main Authors: Denny, Olivia, Woodruff, Ashley E, Mills, Kevin, Chilbert, Maya R
• Format: Journal Article
• Language: English
• Published: United States 29.04.2022

Tirofiban has been used historically as a bridge to platelet inhibition with clopidogrel in ST-segment myocardial infarction (STEMI) during percutaneous coronary intervention (PCI) to prevent stent thrombosis. However, ticagrelor and prasugrel reach similar levels of platelet inhibition at thirty mi...